Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil?

AUTOR(ES)

Rossi, Flavia, Girardello, Raquel, Morais, Carlos, Cury, Ana Paula, Martins, Layla Farage, da Silva, Aline Maria, Abdala, Edson, Setubal, João Carlos, da Silva Duarte, Alberto José

FONTE

Clinics

DATA DE PUBLICAÇÃO

2017-10

RESUMO

OBJECTIVE: We describe an IncX4 pHC891/16mcr plasmid carrying mcr-1 in a colistin-resistant and carbapenem-susceptible E. coli isolate (HC891/16), ST156, which caused a blood infection in a Brazilian patient with gallbladder adenocarcinoma. METHODS: Strain HC891/16 was subjected to whole genome sequencing using the MiSeq Platform (Illumina, Inc., USA). Assembly was performed using Mira and ABACAS. RESULTS: The isolates showed resistance only to ciprofloxacin, ampicillin and cefoxitin, and whole-genome sequencing revealed the presence of aac(6’)Ib-cr and blaTEM1. CONCLUSION: Our findings warn of the possible silent dissemination of colistin resistance by carbapenem-susceptible mcr-1 producers, as colistin susceptibility is commonly tested only among carbapenem-resistant isolates.

Documentos Relacionados

• Plasmid-mediated mcr-1 gene in Acinetobacter baumannii and Pseudomonas aeruginosa: first report from Pakistan
• Energetics of plasmid-mediated arsenate resistance in Escherichia coli.
• Plasmid-mediated formaldehyde resistance in Escherichia coli: characterization of resistance gene.
• Plasmid-mediated high-level resistance to erythromycin in Escherichia coli.
• Emergence of Plasmid-Mediated Quinolone Resistance in Escherichia coli in Europe